Quality of life among XXXX .

@entity1 @entity5 @entity148 @entity158 @entity1142
PURPOSE: To identify factors affecting the quality of life (QoL) of @entity5 . @entity1 AND METHODS: One hundred twenty-one @entity1 in complete remission more than 2 years after diagnosis were asked to complete three QoL questionnaires: the European Organization for Research and Treatment of @entity5 (EORTC) QLQ-C30; its colorectal module, QLQ-CR38; and the Duke generic instrument. RESULTS: @entity1 reported less @entity158 (P =.002) than did controls drawn from the general population. EORTC QLQ-C30 physical scores were also higher among @entity5 survivors than in the general Norwegian or German population (P =.0005 and P =.002, respectively). Unexpectedly, stoma @entity1 reported better social functioning than did nonstoma @entity1 (P =.005), with less @entity148 (P =.008) and higher self-esteem (P =.0002). In the present authors' experience, the QLQ-CR38 does not discriminate between these groups. Residual abdominal or pelvic @entity158 and @entity1142 had the most negative influence on QoL. CONCLUSION: QoL is high among @entity5 survivors, including stoma @entity1 . Simultaneous use of several QoL questionnaires appears to have value in follow-up and in monitoring the effects of therapy. The impact of @entity158 and @entity1142 on long-term QoL should be considered when establishing a treatment regimen.
